Efficacy of frovatriptan in the acute treatment of menstrually related migraine: Analysis of a double-blind, randomized, cross-over, multicenter, Italian, comparative study versus rizatriptan

Journal of Headache and Pain

Volumn 12, Issue 6, 2011, Pages 609-615

  Savi, Lidia ^a   Omboni, Stefano ^b   Lisotto, Carlo ^c   Zanchin, Giorgio ^d   Ferrari, Michel D ^e   Zava, Dario ^f   Pinessi, Lorenzo ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b ITALIAN INSTITUTE OF TELEMEDICINE   (Italy)

^c Ospedale Civile San Vito al Tagliamento   (Italy)

^d UNIVERSITY OF PADOVA   (Italy)

^e LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^f Istituto Lusofarmaco d'Italia   (Italy)

Author keywords

Frovatriptan; Menstrually related migraine; Migraine; Rizatriptan

Indexed keywords

FROVATRIPTAN; RIZATRIPTAN;

ADULT; AGED; ANALGESIA; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MENSTRUAL MIGRAINE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; UNSPECIFIED SIDE EFFECT;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; CARBAZOLES; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; ITALY; MENSTRUATION DISTURBANCES; MIDDLE AGED; MIGRAINE DISORDERS; SEROTONIN RECEPTOR AGONISTS; TRIAZOLES; TRYPTAMINES; YOUNG ADULT;

EID: 84855707200     PISSN: 11292369     EISSN: 11292377     Source Type: Journal    
DOI: 10.1007/s10194-011-0366-9     Document Type: Article

References (39)

1. Martin VT, Lipton RB (2008) Epidemiology and biology of menstrual migraine. Headache 48(Suppl 3):S124-S130
2. Allais G, Castagnoli Gabellari I, De Lorenzo C, Mana O, Benedetto C (2007) Menstrual migraine: Clinical and therapeutical aspects. Expert Rev Neurother 7:1105-1120 (Pubitemid 47451018)
3. Recober A, Geweke LO (2005) Menstrual migraine. Curr Neurol Neurosci Rep 5:93-98 (Pubitemid 40485484)
4. MacGregor EA (2010) Prevention and treatment of menstrual migraine. Drugs 70:1799-1818
5. Mannix LK, Files JA (2005) The use of triptans in the management of mestrua migraine. CNS Drugs 19:951-972 (Pubitemid 41573611)
6. Facchinetti F, Allais G, Nappi RE, Gabellari IC, Di Renzo GC, Genazzani AR, Bellafronte M, Roncolato M, Benedetto C (2010) Sumatriptan (50 mg tablets vs. 25 mg suppositories) in the acute treatment of menstrually related migraine and oral contraceptiveinduced menstrual migraine: A pilot study. Gynecol Endocrinol 26:773-779
7. Mannix LK, Martin VT, Cady RK, Diamond ML, Lener SE, White JD, Derosier FJ, McDonald SA (2009) Combination treatment for menstrual migraine and dysmenorrhea using sumatriptan-naproxen: Two randomized controlled trials. Obstet Gynecol 114:106-113
8. Schreiber CP, Cady RK (2007) Diagnosis of menstrual headache and an open-label study among those with previously undiagnosed menstrually related migraine to evaluate the efficacy of sumatriptan 100 mg. Clin Ther 29(Suppl):2511-2519 (Pubitemid 350299455)
9. Dowson AJ, Massiou H, Aurora SK (2005) Managing migraine headaches experienced by patients who self-report with menstrually related migraine: A prospective, placebo-controlled study with oral sumatriptan. J Headache Pain 6:81-87 (Pubitemid 40667559)
10. Landy S, Savani N, Shackelford S, Loftus J, Jones M (2004) Efficacy and tolerability of sumatriptan tablets administered during the mild-pain phase of menstrually associated migraine. Int J Clin Pract 58:913-919 (Pubitemid 39642611)
11. Nett R, Landy S, Shackelford S, Richardson MS, Ames M, Lener M (2003) Pain-free efficacy after treatment with sumatriptan in the mild pain phase of menstrually associated migraine. Obstet Gynecol 102:835-842 (Pubitemid 37206421)
12. Salonen R, Saiers J (1999) Sumatriptan is effective in the treatment of mestrua migraine: A review of prospective studies and retrospective analyses. Cephalalgia 19:16-19 (Pubitemid 29136846)
13. Tuchman M, Hee A, Emeribe U, Silberstein S (2006) Efficacy and tolerability of zolmitriptan oral tablet in the acute treatment of menstrual migraine. CNS Drugs 20:1019-1026 (Pubitemid 44912709)
14. Allais G, Acuto G, Cabarrocas X, Esbri R, Benedetto C, Bussone G (2006) Efficacy and tolerability of almotriptan versus zolmitriptan for the acute treatment of menstrual migraine. Neurol Sci 27(Suppl 2):S193-S197 (Pubitemid 44390141)
15. Loder E, Silberstein SD, Abu-Shakra S, Mueller L, Smith T (2004) Efficacy and tolerability of oral zolmitriptan in menstrually associated migraine: A randomized, prospective, parallel-group, double-blind, placebo-controlled study. Headache 44:120-130 (Pubitemid 38233753)
16. Massiou H, Jamin C, Hinzelin G, Bidaut-Mazel C, French Naramig Collaborative Study Group (2005) Efficacy of oral naratriptan in the treatment of menstrually related migraine. Eur J Neurol 12:774-781 (Pubitemid 41495134)
17. Bigal M, Sheftell F, Tepper S, Tepper D, Ho TW, Rapoport A (2008) A randomized double-blind study comparing rizatriptan, dexamethasone, and the combination of both in the acute treatment of menstrually related migraine. Headache 48:1286-1293
18. Nett R, Mannix LK, Mueller L, Rodgers A, Hustad CM, Skobieranda F, Ramsey KE (2008) Rizatriptan efficacy in ICHD-II pure menstrual migraine and menstrually related migraine. Headache 48:1194-1201
19. Martin V, Cady R, Mauskop A, Seidman LS, Rodgers A, Hustad CM, Ramsey KE, Skobieranda F (2008) Efficacy of rizatriptan for menstrual migraine in an early intervention model: A prospective subgroup analysis of the rizatriptan TAME (Treat A Migraine Early) studies. Headache 48:226-235 (Pubitemid 351178285)
20. Silberstein SD, Massiou H, McCarroll KA, Lines CR (2002) Further evaluation of rizatriptan in menstrual migraine: Retrospective analysis of long-term data. Headache 42:917-923 (Pubitemid 35285385)
21. Silberstein SD, Massiou H, Le Jeunne C, Johnson-Pratt L, Mc- Carroll KA, Lines CR (2000) Rizatriptan in the treatment of menstrual migraine. Obstet Gynecol 96:237-242 (Pubitemid 30447346)
22. Diamond ML, Cady RK, Mao L, Biondi DM, Finlayson G, Greenberg SJ, Wright P (2008) Characteristics of migraine attacks and responses to almotriptan treatment: A comparison of menstrually related and nonmenstrually related migraines. Headache 48:248-258 (Pubitemid 351178257)
23. Newman LC, Harper S, Jones BA, Campbell J (2009) Frovatriptan for acute treatment of migraine associated with menstruation: Results from an open-label postmarketing surveillance study. J Womens Health (Larchmt) 18:1265-1273
24. Pringsheim T, Davenport WJ, Dodick D (2008) Acute treatment and prevention of menstrually related migraine headache: Evidence- based review. Neurology 70:1555-1563 (Pubitemid 351589510)
25. MacGregor EA, Pawsey SP, Campbell JC, Hu X (2010) Safety and tolerability of frovatriptan in the acute treatment of migraine and prevention of menstrual migraine: Results of a new analysis of data from five previously published studies. Gend Med 7:88-108
26. Brandes JL, Poole A, Kallela M, Schreiber CP, MacGregor EA, Silberstein SD, Tobin J, Shaw R (2009) Short-term frovatriptan for the prevention of difficult-to-treat menstrual migraine attacks. Cephalalgia 29:1133-1148
27. Silberstein SD, Berner T, Tobin J, Xiang Q, Campbell JC (2009) Scheduled short-term prevention with frovatriptan for migraine occurring exclusively in association with menstruation. Headache 49:1283-1297
28. Silberstein SD, Elkind AH, Schreiber C, Keywood C (2004) A randomized trial of frovatriptan for the intermittent prevention of menstrual migraine. Neurology 63:261-269 (Pubitemid 38971124)
29. Guidotti M, Mauri M, Barrilà C, Guidotti F, Belloni C (2007) Frovatriptan vs. transdermal oestrogens or naproxen sodium for the prophylaxis of mestrual migraine. J Headache Pain 8:283-288 (Pubitemid 350214726)
30. Balbisi EA (2006) Frovatriptan: A review of pharmacology, pharmacokinetics and clinical potential in the treatment of menstrual migraine. Ther Clin Risk Manag 2:303-308 (Pubitemid 44349505)
31. Allais G, Bussone G, Airola G, Borgogno P, Gabellari IC, De Lorenzo C, Pavia E, Benedetto C (2008) Oral contraceptiveinduced menstrual migraine. Clinical aspects and response to frovatriptan. Neurol Sci 29(Suppl 1):S186-S190 (Pubitemid 351836998)
32. Newman LC, Harper S, Jones BA, Campbell J (2009) Frovatriptan for acute treatment of migraine associated with menstruation: Results from an open-label postmarketing surveillance study. J Womens Health (Larchmt) 18:1265-1273
33. Savi L, Omboni S, Lisotto C, Zanchin G, Ferrari MD, Zava D, Pinessi L (2011) A double-blind, randomized, multicenter, Italian study of frovatriptan versus rizatriptan for the acute treatment of migraine. J Headache Pain 12:219-226
34. Headache Classification Subcommittee of the International Headache Society (2004) The International Classification of Headache Disorders, 2nd edn. Cephalalgia 24(Suppl 1):9-160
35. Loder E (2010) Triptan therapy in migraine. N Engl J Med 363:63-70
36. Balbisi EA (2004) Frovatriptan succinate, a 5-HT1B/1D receptor agonist for migraine. Int J Clin Pract 58:695-705 (Pubitemid 39144585)
37. Markus F, Mikko K (2007) Frovatriptan review. Expert Opin Pharmacother 8:3029-3033 (Pubitemid 350285016)
38. Kelman L (2008) Review of frovatriptan in the treatment of migraine. Neuropsychiatr Dis Treat 4:49-54 (Pubitemid 351460979)
39. Cady R, Elkind A, Goldstein J, Keywood C (2004) Randomized, placebo-controlled comparison of early use of frovatriptan in a migraine attack versus dosing after the headache has become moderate or severe. Curr Med Res Opin 20:1465-1472 (Pubitemid 39361351)